Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjögren's syndrome

Arthritis Research and Therapy

Volumn 9, Issue , 2007, Pages

  Willeke, Peter ^a   Gaubitz, Markus ^a   Schotte, Heiko ^a   Maaser, Christian ^a   Domschke, Wolfram ^a   Schlüter, Bernhard ^a   Becker, Heidemarie ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CYTOKINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GAMMA INTERFERON; HLA DR ANTIGEN; HLA DR3 ANTIGEN; HYDROXYCHLOROQUINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; LA ANTIBODY; MACROPHAGE MIGRATION INHIBITION FACTOR; RHEUMATOID FACTOR; RO ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; GENOTYPE; HUMAN; HUMAN CELL; HYPERGAMMAGLOBULINEMIA; IMMUNOCHEMISTRY; IMMUNOPATHOGENESIS; LABORATORY TEST; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEROLOGY; SJOEGREN SYNDROME; BLOOD; GENETICS; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; SJOGREN'S SYNDROME;

EID: 34249307813     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2182     Document Type: Article

References (45)

1. Kassan SS Thomas TL Moutsopoulos HM Hoover R Kimberly RP Budman DR Costa J Decker JL Chused TM Increased risk of lymphoma in sicca syndrome Ann Intern Med 1978 89 888-892 102228
2. David JR Delayed hypersensitivity in vitro: Its mediation by cell-free substances formed by lymphoid cell-antigen interaction Proc Natl Acad Sci USA 1966 56 72-77 285677 5229858 10.1073/pnas.56.1.72
3. Bloom BR Bennett B Mechanism of a reaction in vitro associated with delayed-type hypersensitivity Science 1966 153 80-82 10.1126/ science.153.3731.80 5938421
4. Weiser WY Pozzi LM Titus RG David JR Recombinant human migration inhibitory factor has adjuvant activity Proc Natl Acad Sci USA 1992 89 8049-8052 49853 1518830 10.1073/pnas.89.17.8049
5. Larson DF Horak K Macrophage migration inhibitory factor: Controller of systemic inflammation Crit Care 2006 10 138 1550887 16677407 10.1186/ cc4899
6. Bucala R Lolis E Macrophage migration inhibitory factor: A critical component of autoimmune inflammatory diseases Drug News Perspect 2005 18 417-426 10.1358/dnp.2005.18.7.939345 16362080
7. Donn R Alourfi Z De Benedetti F Meazza C Zeggini E Lunt M Stevens A Shelley E Lamb R Ollier WE Mutation screening of the macrophage migration inhibitory factor gene: Positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis Arthritis Rheum 2002 46 2402-2409 10.1002/art.10492 12355488
8. Morand EF Leech M Weedon H Metz C Bucala R Smith MD Macrophage migration inhibitory factor in rheumatoid arthritis: Clinical correlations Rheumatology (Oxford) 2002 41 558-562 10.1093/rheumatology/41.5.558 12011381
9. Becker H Maaser C Mickholz E Dyong A Domschke W Gaubitz M Relationship between serum levels of macrophage migration inhibitory factor and the activity of antineutrophil cytoplasmic antibody-associated vasculitides Clin Rheumatol 2006 25 368-372 10.1007/s10067-005-0045-9 16391884
10. Foote A Briganti EM Kipen Y Santos L Leech M Morand EF Macrophage migration inhibitory factor in systemic lupus erythematosus J Rheumatol 2004 31 268-273 14760795
11. Azuma M Motegi K Aota K Hayashi Y Sato M Role of cytokines in the destruction of acinar structure in Sjogren's syndrome salivary glands Lab Invest 1997 77 269-280 9314950
12. Ohyama Y Nakamura S Matsuzaki G Shinohara M Hiroki A Fujimura T Yamada A Itoh K Nomoto K Cytokine messenger RNA expression in the labial salivary glands of patients with Sjogren's syndrome Arthritis Rheum 1996 39 1376-1384 10.1002/art.1780390816 8702447
13. Vitali C Bombardieri S Jonsson R Moutsopoulos HM Alexander EL Carsons SE Daniels TE Fox PC Fox RI Kassan SS Classification criteria for Sjogren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group Ann Rheum Dis 2002 61 554-558 1754137 12006334 10.1136/ard.61.6.554
14. Maaser C Eckmann L Paesold G Kim HS Kagnoff MF Ubiquitous production of macrophage migration inhibitory factor by human gastric and intestinal epithelium Gastroenterology 2002 122 667-680 10.1053/gast.2002.31891 11875000
15. Willeke P Schotte H Erren M Schlüter B Mickholz E Domschke W Gaubitz M Concomitant reduction of disease activity and IL-10 secreting peripheral blood mononuclear cells during immunoadsorption in patients with active systemic lupus erythematosus Cell Mol Biol (Noisy-le-grand) 2002 48 323-329 12030438
16. Vaquerano JE Peng M Chang JW Zhou YM Leong SP Digital quantification of the enzyme-linked immunospot (ELISPOT) Biotechniques 1998 25 830-834, 836 9821585
17. Willeke P Schluter B Schotte H Erren M Mickholz E Domschke W Gaubitz M Increased frequency of GM-CSF secreting PBMC in patients with active systemic lupus erythematosus can be reduced by immunoadsorption Lupus 2004 13 257-262 10.1191/0961203304lu1009oa 15176662
18. Vitali C Tavoni A Simi U Marchetti G Vigorito P d'Ascanio A Neri R Cristofani R Bombardieri S Parotid sialography and minor salivary gland biopsy in the diagnosis of Sjogren's syndrome. A comparative study of 84 patients J Rheumatol 1988 15 262-267 3258917
19. Pillemer SR Smith J Fox PC Bowman SJ Outcome measures for Sjogren's syndrome, April 10-11, Bethesda, Maryland, USA J Rheumatol 2005 32 143-149 15630740
20. Gottenberg JE Busson M Cohen-Solal J Lavie F Abbed K Kimberly RP Sibilia J Mariette X Correlation of serum B lymphocyte stimulator and β2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome Ann Rheum Dis 2005 64 1050-1055 10.1136/ ard.2004.030643 15640273
21. Chesney J Metz C Bacher M Peng T Meinhardt A Bucala R An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma Mol Med 1999 5 181-191 10404515
22. Bacher M Metz CN Calandra T Mayer K Chesney J Lohoff M Gemsa D Donnelly T Bucala R An essential regulatory role for macrophage migration inhibitory factor in T-cell activation Proc Natl Acad Sci USA 1996 93 7849-7854 38837 8755565 10.1073/pnas.93.15.7849
23. Popa C van Lieshout AW Roelofs MF Geurts-Moespot A van Riel PL Calandra T Sweep FC Radstake TR MIF production by dendritic cells is differentially regulated by Toll-like receptors and increased during rheumatoid arthritis Cytokine 2006 36 51-56 10.1016/j.cyto.2006.10.011 17166737
24. Calandra T Bernhagen J Metz CN Spiegel LA Bacher M Donnelly T Cerami A Bucala R MIF as a glucocorticoid-induced modulator of cytokine production Nature 1995 377 68-71 10.1038/377068a0 7659164
25. de Mendonca-Filho HT Gomes GS Nogueira PM Fernandes MA Tura BR Santos M Castro-Faria-Neto HC Macrophage migration inhibitory factor is associated with positive cultures in patients with sepsis after cardiac surgery Shock 2005 24 313-317 10.1097/01.shk.0000180622.52058.3a 16205314
26. Gottenberg JE Busson M Loiseau P Cohen-Solal J Lepage V Charron D Sibilia J Mariette X In primary Sjogren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response Arthritis Rheum 2003 48 2240-2245 10.1002/art.11103 12905478
27. Halse A Tengner P Wahren-Herlenius M Haga H Jonsson R Increased frequency of cells secreting interleukin-6 and interleukin-10 in peripheral blood of patients with primary Sjogren's syndrome Scand J Immunol 1999 49 533-538 10.1046/j.1365-3083.1999.00533.x 10320647
28. Wu J Cunha FQ Liew FY Weiser WY IL-10 inhibits the synthesis of migration inhibitory factor and migration inhibitory factor-mediated macrophage activation J Immunol 1993 151 4325-4332 7691945
29. Cvetkovic I Al-Abed Y Miljkovic D Maksimovic-Ivanic D Roth J Bacher M Lan HY Nicoletti F Stosic-Grujicic S Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes Endocrinology 2005 146 2942-2951 10.1210/en.2004-1393 15790730
30. Bogdan C Vodovotz Y Nathan C Macrophage deactivation by interleukin 10 J Exp Med 1991 174 1549-1555 10.1084/jem.174.6.1549 1744584
31. Calandra T Bernhagen J Mitchell RA Bucala R The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor J Exp Med 1994 179 1895-1902 10.1084/jem.179.6.1895 8195715
32. de Jong YP Abadia-Molina AC Satoskar AR Clarke K Rietdijk ST Faubion WA Mizoguchi E Metz CN Alsahli M ten Hove T Development of chronic colitis is dependent on the cytokine MIF Nat Immunol 2001 2 1061-1066 10.1038/ ni720 11668338
33. Kudrin A Scott M Martin S Chung CW Donn R McMaster A Ellison S Ray D Ray K Binks M Human macrophage migration inhibitory factor: A proven immunomodulatory cytokine? J Biol Chem 2006 281 29641-29651 10.1074/ jbc.M601103200 16893895
34. Willeke P Gaubitz M Schotte H Becker H Mickholz E Domschke W Schluter B Clinical and immunological characteristics of patients with Sjogren's syndrome in relation to α-fodrin antibodies Rheumatology (Oxford) 2007 46 479-483 10.1093/rheumatology/kel270 16935916
35. Hoi AY Hickey MJ Hall P Yamana J O'Sullivan KM Santos LL James WG Kitching AR Morand EF Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice J Immunol 2006 177 5687-5696 17015758
36. Kong YZ Yu X Tang JJ Ouyang X Huang XR Fingerle-Rowson G Bacher M Scher LA Bucala R Lan HY Macrophage migration inhibitory factor induces MMP-9 expression: Implications for destabilization of human atherosclerotic plaques Atherosclerosis 2005 178 207-215 10.1016/ j.atherosclerosis.2004.08.030 15585220
37. Azuma M Aota K Tamatani T Motegi K Yamashita T Harada K Hayashi Y Sato M Suppression of tumor necrosis factor α-induced matrix metalloproteinase 9 production by the introduction of a super-repressor form of inhibitor of nuclear factor κBα complementary DNA into immortalized human salivary gland acinar cells. Prevention of the destruction of the acinar structure in Sjogren's syndrome salivary glands Arthritis Rheum 2000 43 1756-1767 10.1002/ 1529-0131(200008)43:8<1756::AID-ANR12>3.0.CO;2-H 10943866
38. Liew FY Regulation of nitric oxide synthesis in infectious and autoimmune diseases Immunol Lett 1994 43 95-98 10.1016/ 0165-2478(94)00157-X 7737695
39. Konttinen YT Platts LA Tuominen S Eklund KK Santavirta N Tornwall J Sorsa T Hukkanen M Polak JM Role of nitric oxide in Sjogren's syndrome Arthritis Rheum 1997 40 875-883 10.1002/art.1780400515 9153549
40. Hudson JD Shoaibi MA Maestro R Carnero A Hannon GJ Beach DH A proinflammatory cytokine inhibits p53 tumor suppressor activity J Exp Med 1999 190 1375-1382 10.1084/jem.190.10.1375 10562313
41. Wilson JM Coletta PL Cuthbert RJ Scott N MacLennan K Hawcroft G Leng L Lubetsky JB Jin KK Lolis E Macrophage migration inhibitory factor promotes intestinal tumorigenesis Gastroenterology 2005 129 1485-1503 10.1053/j.gastro.2005.07.061 16285950
42. Beswick EJ Pinchuk IV Suarez G Sierra JC Reyes VE Helicobacter pylori CagA-dependent macrophage migration inhibitory factor produced by gastric epithelial cells binds to CD74 and stimulates procarcinogenic events J Immunol 2006 176 6794-6801 16709839
43. Masaki Y Sugai S Lymphoproliferative disorders in Sjogren's syndrome Autoimmun Rev 2004 3 175-182 10.1016/S1568-9972(03)00102-2 15110228
44. Du M Peng H Singh N Isaacson PG Pan L The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma Blood 1995 86 4587-4593 8541549
45. Talos F Mena P Fingerle-Rowson G Moll U Petrenko O MIF loss impairs Myc-induced lymphomagenesis Cell Death Differ 2005 12 1319-1328 10.1038/ sj.cdd.4401653 15947793